Quiet on the insider front: nobody at CARGO Therapeutics, Inc. bought or sold CRGX shares on the open market this past year.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Radhakrishnan Anup | Officer | Sell | 1,632 | $4.18 | $7K | SEC |
| May 16, 2025 | Radhakrishnan Anup | Officer | Sell | 27,404 | $3.84 | $105K | SEC |
| Apr 8, 2025 | Radhakrishnan Anup | Officer | Sell | 1,629 | $4.00 | $7K | SEC |
| Sep 20, 2024 | Chapman Gina | CEO | Sell | 7,166 | $25.09 | $180K | SEC |
| Sep 20, 2024 | Chapman Gina | CEO | Sell | 2,975 | $25.03 | $74K | SEC |
| Sep 20, 2024 | Radhakrishnan Anup | CFO | Sell | 1,600 | $25.28 | $40K | SEC |
| Jun 3, 2024 | Samsara BioCapital, L.P. | 10% Owner | Buy | 294,000 | $17.00 | $5.0M | SEC |
| Nov 16, 2023 | AKKARAJU SRINIVAS | 10% Owner | Buy | 666,666 | $15.00 | $10.0M | SEC |
| Nov 14, 2023 | TRV GP V, LLC | 10% Owner | Buy | 1,333,333 | $15.00 | $20.0M | SEC |
| Nov 14, 2023 | EDELMAN JOSEPH | Other | Buy | 333,333 | $15.00 | $5.0M | SEC |
| Nov 14, 2023 | EDELMAN JOSEPH | Other | Buy | 333,333 | $15.00 | $5.0M | SEC |
There were no open-market insider trades in CRGX in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in CRGX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).